Liu Linda 4
4 · NextCure, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Liu Linda
SVP, Research
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-31+65,600→ 65,600 totalExercise: $5.57Exp: 2032-01-30→ Common Stock (65,600 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.